Top 10 New Entrants companies in Carbonic anhydrase inhibitor by Most Patent Filing In 5 Years in the world in 2022 – Discovery

Free Trial

The Carbonic anhydrase inhibitor top 10 is Discovery PatSnap’ annual ranking of the top 10 Most Patent Filing In 5 Years Carbonic anhydrase inhibitor New Entrants in the world. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2022, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.

Ranking Year:

Region:

Ranking:

1	Ocuphire Pharma, Inc.	Michigan, United States	OPHTHALMIC DISORDERS,Glaucoma,Eye drop, ...[+2]	Patent: 5
2	STARTUP Somerset Therapeutics LLC	New Jersey, United States	Drug,Ophthalmic drugs,Health care, ...[+1]	Patent: 4
3	Academy of Military Medical Sciences	China	Medical research,Biomedicine,Biotechnology, ...[+2]	Patent: 3
4	Ocugen, Inc.	Pennsylvania, United States	Medicine,Health care,Biopharmaceutical, ...[+2]	Patent: 3
5	Purdue Research Foundation	Indiana, United States	Financial asset,Technology transfer,Incubation, ...[+2]	Patent: 3
6	Hadasit Medical Research Services & Development Ltd.	Jerusalem, Israel	Health care,Technology transfer,Biomedicine, ...[+2]	Patent: 3
7	Seoul National University Hospital	South Korea	Emergency department,Healthcare system,Medical tourism, ...[+2]	Patent: 2
8	Southeast University	Jiangsu Sheng, China	Mechanical engineering,Molecular beam epitaxy,Retinitis, ...[+2]	Patent: 2
9	National Center for Nanoscience & Technology	Beijing Shi, China	Nanotechnology,Dendritic cell,Cell sorting, ...[+2]	Patent: 2
10	The Brigham & Women's Hospital, Inc.	Massachusetts, United States	Health care,Mitral valve surgery,Health equity, ...[+2]	Patent: 2